Condition
Advanced Malignant Tumors clinical trials and research
As of November 12, 2026, Find a Trial lists 10 Advanced Malignant Tumors clinical trials that are recruiting, at sites in 4 countries (most in China (8), Australia (2), Canada (1)). By phase: Phase 1 (7), Phase 1/2 (3). The most active sponsors are Shenyang Sunshine Pharmaceutical Co., LTD. (3), Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (2), SUNHO(China)BioPharmaceutical CO., Ltd. (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 10Clinical trials
- 4Countries
Newest Advanced Malignant Tumors clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| See if TQB3142 is tolerated and how it behaves in people with advanced cancers | Phase 1 | Guangzhou, Guangdong and 4 other locations | Recruiting | Jan 14, 2026 |
| TQB6411 injection for advanced EGFR/c‑Met–expressing solid tumors | Phase 1 | Beijing, Beijing Municipality and 18 other locations | Recruiting | Jun 29, 2025 |
| SPGL008 given by IV or under-the-skin injection for advanced malignant tumors | Phase 1 | Chongqing, Chongqing Municipality | Recruiting | Jun 26, 2025 |
| Phase 1 SSGJ-612 for advanced HER2‑positive solid tumors | Phase 1 | Luoyang, Henan | Recruiting | Jun 23, 2025 |
| SSGJ-709 for people with advanced malignant tumors | Phase 1 | Adelaide | Recruiting | Jun 11, 2025 |
| Investigating JMT108 Injection for Advanced Malignant Tumors | Phase 1/2 | Shanghai, Shanghai Municipality | Recruiting | Mar 14, 2025 |
| Testing BMS-986488 for advanced malignant tumors | Phase 1 | Hackensack, New Jersey and 7 other locations | Recruiting | Jan 8, 2025 |
| Evaluating IAP0971 for patients with advanced malignant tumors | Phase 1/2 | Beijing, Beijing Municipality | Recruiting | Jan 25, 2024 |
| Evaluating IBB0979 for Advanced Malignant Tumors | Phase 1/2 | Shanghai, Shanghai Municipality | Recruiting | Aug 14, 2023 |
| Evaluating NBL-020 Injection for Advanced Malignant Tumors | Phase 1 | Guanzhou, Guangdong | Recruiting | May 26, 2023 |
All recruiting trials (10)
-
See if TQB3142 is tolerated and how it behaves in people with advanced cancers
This early-phase test checks whether TQB3142 injections are safe to use and how the drug moves through the body in adults with advanced tumors.
-
TQB6411 injection for advanced EGFR/c‑Met–expressing solid tumors
This phase 1 trial tests TQB6411, an antibody–drug that targets EGFR and c‑Met, to try to kill tumor cells in adults with advanced solid tumors who have exhausted standard treatments.
-
SPGL008 given by IV or under-the-skin injection for advanced malignant tumors
This trial will test whether SPGL008 given intravenously or under the skin is safe and shows early signs of benefit in adults with advanced malignant tumors.
-
Phase 1 SSGJ-612 for advanced HER2‑positive solid tumors
This trial will test SSGJ-612, a new drug, in adults with advanced HER2‑expressing solid tumors who have exhausted standard treatments.
-
SSGJ-709 for people with advanced malignant tumors
This clinical trial will try SSGJ-709, an experimental intravenous drug given every three weeks, in people with advanced malignant tumors who have exhausted or cannot receive standard treatments to see if it is safe and shows anti-tumor activity.
-
Investigating JMT108 Injection for Advanced Malignant Tumors
This study is testing a new injection called JMT108 to see if it is safe and can help people with advanced tumors that haven't responded to other treatments.
-
Testing BMS-986488 for advanced malignant tumors
This study is testing a new treatment called BMS-986488 to see if it can help people with advanced cancers feel better and fight their disease, either on its own or with other therapies.
-
Evaluating IAP0971 for patients with advanced malignant tumors
This study is testing a new drug called IAP0971 to see if it is safe and effective for people with advanced malignant tumors, especially those who haven't had success with other treatments.
-
Evaluating IBB0979 for Advanced Malignant Tumors
This study is testing a new treatment called IBB0979 to see if it can help people with advanced malignant tumors who have already tried other options.
-
Evaluating NBL-020 Injection for Advanced Malignant Tumors
This study is testing a new injection called NBL-020 to see if it is safe and effective for people with advanced malignant tumors.
Quick answers
How many Advanced Malignant Tumors clinical trials are recruiting right now?
10, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in China (8 trials), Australia (2 trials), Canada (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 7, Phase 1/2: 3. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.